Protagonist Therapeutics PTGX Other Accounts Payable and Accrued Liabilities
Other Accounts Payable and Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAccountsPayableAndAccruedLiabilities.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's other accounts payable and accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's other accounts payable and accrued liabilities?
- Protagonist Therapeutics (PTGX) reported other accounts payable and accrued liabilities of $17.49M in Q1 2026.
- How has Protagonist Therapeutics's other accounts payable and accrued liabilities changed year-over-year?
- Protagonist Therapeutics's other accounts payable and accrued liabilities increased by 47.7% year-over-year, from $11.84M to $17.49M.
- What is the long-term trend for Protagonist Therapeutics's other accounts payable and accrued liabilities?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's other accounts payable and accrued liabilities has grown at a 8.9% compound annual growth rate (CAGR), from $18.5M to $28.27M.